Latest DEF 14A proxy statements
NASDAQ
Supernus Pharmaceuticals schedules its 2026 Annual Meeting of Stockholders for June 18, 2026, to address director elections, executive compensation, and equity plan expansion.
ACCESS Newswire Inc. has issued its 2026 proxy statement, outlining the agenda for the upcoming virtual annual meeting of stockholders scheduled for June 26, 2026.
NASDAQ
Rackspace Technology, Inc. has issued its 2026 Proxy Statement, outlining key proposals including director elections, auditor ratification, and an amendment to its 2020 Equity Incentive Plan.
NASDAQ
AIRG
Airgain INCAirgain, Inc. announces its 2026 Annual Meeting of Stockholders to elect directors, ratify auditors, and approve an amended 2016 Incentive Award Plan.
NASDAQ
Eledon Pharmaceuticals announces its 2026 Annual Meeting of Stockholders to elect directors, increase authorized shares, and ratify its auditor.
NASDAQ
Riot Platforms announces its 2026 Annual Meeting, focusing on board declassification, executive compensation, and equity plan expansion.
NYSE
ANVS
Annovis Bio, INCAnnovis Bio, Inc. has issued its 2026 proxy statement detailing director elections, auditor ratification, and proposed equity plan amendments.
NASDAQ
Scilex Holding Company announces its 2026 Annual Meeting of Stockholders to be held virtually on June 24, 2026.
NASDAQ
PLBY
Plby Group, INCPlayboy, Inc. has scheduled its 2026 Annual Meeting for June 16, 2026, to vote on director elections and a 10 million share increase to its equity incentive plan.
NASDAQ
MidCap Financial Investment Corporation announces its 2026 Annual Meeting of Stockholders to be held virtually on June 18, 2026, to vote on director elections and auditor ratification.
NASDAQ
TBLA
Taboolacom LTDTaboola.com Ltd. announces its 2026 Annual General Meeting to vote on director re-elections, executive compensation policies, and auditor reappointment.
NASDAQ
ALTI
Alti Global, INCAlTi Global, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation.
Semnur Pharmaceuticals, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 25, 2026.
NASDAQ
Light & Wonder outlines executive compensation, director elections, and strategic 2028 financial goals following its transition to a sole ASX listing.
NASDAQ
Ollie's Bargain Outlet achieved record store openings and exceeded Adjusted EBITDA targets in fiscal 2025, positioning the retailer for long-term expansion toward a 1,300-store goal.
NASDAQ
FEMY
Femasys INCFemasys Inc. has scheduled its 2026 Annual Meeting for June 24 to elect directors, ratify its independent auditor, and provide updates on executive compensation and corporate governance.
AMEX
AgEagle Aerial Systems Inc. has scheduled its virtual annual meeting for June 15, 2026, to vote on director elections and executive compensation following a year of significantly narrowed losses.
NYSE
Equus Total Return, Inc. has issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders scheduled for June 30, 2026.
AMEX
Intellinetics, Inc. announces its 2026 Annual Meeting of Stockholders to vote on director elections, equity plan amendments, and executive compensation.
NYSE
StubHub Holdings, Inc. has issued its 2026 proxy statement detailing the upcoming virtual annual meeting, director elections, and executive compensation advisory votes.
AMEX
Theriva Biologics has scheduled a special meeting for June 5, 2026, to seek stockholder approval for the issuance of shares related to a 2025 private placement warrant exercise.
NASDAQ
SAB Biotherapeutics, Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 18, 2026.
Amaze Holdings, Inc. will hold its 2026 Annual Meeting to vote on proposals including a new equity plan, convertible note share issuance, and a substantial increase in authorized common stock, all pointing to significant potential dilution.
NASDAQ
Lifeway Foods, Inc. has issued its 2026 proxy statement detailing director elections, auditor ratification, and executive compensation proposals.
NASDAQ
BFRI
Biofrontera INCBiofrontera Inc. has scheduled its 2026 Annual Meeting of Stockholders for June 11, 2026, to vote on director elections, an increase in equity plan shares, and auditor ratification.
AMEX
Empire Petroleum Corporation announces its 2026 Annual Meeting of Stockholders to be held on June 17, 2026, to vote on director elections, executive compensation, and a new incentive plan.
NASDAQ
FGI Industries Ltd. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and auditor ratification.
NASDAQ
MiNK Therapeutics announces its 2026 Annual Meeting of Stockholders to be held virtually on June 17, 2026.
NASDAQ
Allogene Therapeutics announces its 2026 Annual Meeting, seeking shareholder approval to double authorized common stock to 800 million shares.
NASDAQ
Broadway Financial Corporation has scheduled its 2026 Annual Meeting of Stockholders for June 17, 2026, to conduct routine governance and compensation votes.